Loading clinical trials...
Loading clinical trials...
The Effects of the Histamine-3 Receptor Inverse Agonist Pitolisant on Alcohol Self-Administration in Heavy Drinkers
Conditions
Interventions
Pitolisant
Placebo
Locations
1
United States
Boston University Psychiatry Research Center, Clinical Studies Unit
Boston, Massachusetts, United States
Start Date
September 13, 2021
Primary Completion Date
February 3, 2023
Completion Date
February 3, 2023
Last Updated
December 4, 2023
NCT07027839
NCT06002633
NCT05766761
NCT06552741
NCT07279558
NCT07341230
Lead Sponsor
Boston Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions